Print This Page Print This Page    Email this page to a Friend Email this page to a Friend
News Releases
Palmetto Health Announces Breast Milk Supply Program for Preemies in its Neonatal Intensive Care Units

Palmetto Health Announces Breast Milk Supply Program for
Preemies in its Neonatal Intensive Care Units

Partnership with Prolacta Bioscience is One of the First in Nation to Ensure a Safe, Standardized and Steady Supply of Pasteurized Donor Milk to the Hospital System’s Hospitalized Premature Infants 

COLUMBIA, S.C.—Palmetto Health is partnering with Prolacta Bioscience, Inc. to create the Palmetto Health Donor Milk Program. The partnership, one of the first in the nation, will provide a safe, standardized and steady supply of pasteurized donor breast milk to the health care system’s premature infants in the Neonatal Intensive Care Units (NICU). Under the partnership, Prolacta will manage the breast milk donor qualification process by conducting health screenings, blood testing and the milk collection process for the newly established program. Prolacta also will conduct safety and quality testing before pasteurizing the human milk products for in-hospital use. Palmetto Health will work with the community to increase awareness among moms who have surplus of breast milk to donate.

“Palmetto Health has been an advocate for human milk nutrition for preemies for some time and has seen the benefits in the babies cared for at its hospitals” said Victor Iskersky, M.D., medical director of the Neonatal Intensive Care Unit at Palmetto Health Richland. “Once we began exclusively using human milk based diet including fortifier and donor milk for preemies that didn’t have access to their mother’s milk, we noticed a dramatic decrease in necrotizing enterocolitis (NEC) which is often a devastating disease in preemies resulting in profound short-term and long-term complications including death. We know how effective this is so we are pleased that this partnership with Prolacta will ensure that we have breast milk to meet the needs of the critically ill premature infants in our NICUs.”

Donor moms will be able to donate without ever having to leave the comfort of their own homes, and the family doesn’t incur any out-of-pocket expenses. The initial screening is done online, certified phlebotomists come to the mother’s home, and all of the storage and shipping supplies are sent directly to the mom. Shipment pick-up is then arranged so that the donating mother and her baby won’t be burdened by having to drive the shipment coolers anywhere. For many moms, this will come as a welcome option, since many struggle with what to do with their extra breast milk, and they will now be able to support premature infants in their community, through a process made easy and convenient by Prolacta.                                         

There is growing evidence and data supporting the health benefits of an exclusive breast milk diet for premature infants in the NICU, as opposed to cow milk-based nutrition or formula. The American Academy of Pediatrics reinforced this with their 2012 policy statement on breastfeeding and the use of human milk, pointing to a reduction in the odds of developing the often-fatal disease necrotizing enterocolitis in extremely preterm infants (those born weighing 500-1250g), when fed an exclusively human milk diet, when compared to those fed a diet consisting of cow milk-based proteins. A recent study published in the Journal of Pediatrics reinforced this, concluding that extremely premature infants who are fed an exclusive human milk diet instead of preterm formula have a significantly lower incidence of surgery associated with NEC and require fewer days of intravenous feedings through total parenteral nutrition (TPN). 

“We are pleased to partner with Palmetto Health. By working together, we can ensure their community has a steady supply of standardized, safe and specially formulated donor breast milk to help optimize growth in their hospitalized preterm infants,” said Scott Elster, CEO of Prolacta Bioscience, Inc. “We have begun working with communities across the nation in which we can help address the supply issue that hospitals are facing, and we are delighted that Palmetto Health is joining us in this endeavor to help improve the outcomes of extremely premature infants.”

Prolacta is the only organization in the nation to include a rigorous donor qualification and milk collection process, a safety combination of DNA matching of mom to milk, testing for drugs and other contamination. Pooled donor milk is tested for HIV-1, HCV, and HBV using PCR tests to ensure the highest-quality available human milk products to feed the sickest infants in NICU. In addition, pooled milk, as well as finished product is tested for contamination, including specific tests for Salmonella and coliform bacteria including E. coli. Palmetto Health will become one of the first in the country to establish a hospital donor milk program. Since human breast milk is highly variable, the standardization is significant because Palmetto Health will now be able to provide donor milk with a precise amount of calories and protein, enabling targeted nutrition to help ensure appropriate growth in preemies. This ability to standardize donor milk takes the guesswork out of the equation for neonatologists who need to prescribe specific nutrition for fragile preemies.

For more information about donating breast milk, call 855-348-5274 or visit


About Palmetto Health
Palmetto Health, the largest health care system in the Midlands and third largest non-governmental employer in South Carolina, is composed of more than 10,000 team members, physicians and volunteers working together to fulfill Palmetto Health’s vision: to be remembered by each patient as providing the care and compassion we want for our families and ourselves. The system includes four acute-care hospitals—Palmetto Health Baptist, Palmetto Health Children’s Hospital, Palmetto Health Heart Hospital and Palmetto Health Richland—as well as an expansive physician practice network, dozens of affiliated clinics and specialty care practices and a 501(c)(3) foundation. Palmetto Health Baptist Parkridge, the region’s newest hospital located in northwest Columbia, is scheduled to open spring 2014. Recognized nationally as one of the best places to work and receive care, Palmetto Health also trains the next generation of physicians through its 23 residency and fellowship programs affiliated with the University of South Carolina School of Medicine. For more information, visit

About Prolacta Bioscience
Prolacta Bioscience, Inc. is a life science company dedicated to improving quality of life by Advancing the Science of Human Milk™. Prolacta creates specialty formulations made exclusively from human milk for the nutritional needs of critically ill, premature infants in NICU. It is the first and only company to provide a commercially available human milk fortifier made from 100 percent human milk, Prolact+ H2MF®. Prolacta operates a pharmaceutical grade processing plant and have designed and patented processes that enable them to make their one-of-a-kind products. Prolacta is committed to making a meaningful difference in the lives of the most vulnerable premature babies through world-class research and innovative products.